ChromaGen

ChromaGen is a medical technology company specializing in the development and commercialization of proprietary optical filters designed to treat visual processing disorders. The company's primary product line consists of FDA-cleared lenses and contact lenses that utilize specific wavelengths of light to synchronize neural signals from the eyes to the brain. This technology is primarily used to manage color vision deficiency (color blindness) and has demonstrated efficacy in alleviating symptoms of dyslexia and visual stress by improving reading speed and comprehension. ChromaGen operates globally, providing non-invasive solutions for patients who struggle with traditional corrective methods for visual and reading impairments.